USTEKINUMAB TROUGH LEVELS ARE ASSOCIATED WITH SONOGRAPHIC TRANSMURAL HEALING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Kellar, Amelia
Aronskyy, Illya
Dubinsky, Marla C.
Dolinger, Michael T.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1996
引用
收藏
页码：S1180 / S1180
页数：1
相关论文
共 50 条
  • [41] Vedolizumab trough levels predict clinical outcomes in inflammatory bowel disease
    Guidi, L.
    Pugliese, D.
    Tonucci, T. Panici
    Tolusso, B.
    Felice, C.
    Di Mario, C.
    Papa, A.
    Gremese, E.
    Gasbarrini, A.
    Rapaccini, G. L.
    Armuzzi, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S398 - S398
  • [42] Infliximab Dosing for Patients With Inflammatory Bowel Disease, Based on Trough Levels
    Lowe, Anson W.
    Moseley, Richard H.
    GASTROENTEROLOGY, 2015, 148 (07) : 1261 - 1261
  • [43] Clinical utility of vedolizumab trough levels in the management of inflammatory bowel disease
    Maillard, Michel H.
    Jelk, Daniele
    Perreau, Matthieu
    Rossel, Jean-Benoit
    Pittet, Valerie
    Michetti, Pierre
    SWISS MEDICAL WEEKLY, 2018, 148 : 6S - 6S
  • [44] Success and safety of high infliximab trough levels in inflammatory bowel disease
    Drobne, David
    Kurent, Tina
    Golob, Sasa
    Svegl, Polona
    Rajar, Polona
    Terzic, Sara
    Kozelj, Matic
    Novak, Gregor
    Smrekar, Natasa
    Plut, Samo
    Sever, Nejc
    Strnisa, Luka
    Hanzel, Jurij
    Brecelj, Jernej
    Urlep, Darja
    Osredkar, Josko
    Homan, Matjaz
    Orel, Rok
    Stabuc, Borut
    Ferkolj, Ivan
    Smid, Alojz
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (08) : 940 - 946
  • [45] Ustekinumab levels in pregnant women with inflammatory bowel disease and neonates exposed in utero
    Prentice, R.
    Flanagan, E.
    Wright, E. K.
    Ross, A.
    Gibson, P. R.
    Rosella, O.
    Kilburg, K. V.
    Bell, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 91 - 92
  • [46] Monitoring ustekinumab levels in Inflammatory Bowel Disease in clinical practice: a window of opportunity
    Gonzalez Antuna, J.
    Valdes Delgado, T.
    Maldonado Perez, B.
    Castro Laria, L.
    Merino Bohorquez, V.
    Calleja Hernandez, M. A.
    Arguelles Arias, F.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1299 - I1300
  • [47] Treat to transmural healing: how to incorporate intestinal ultrasound into the treatment of inflammatory bowel disease
    Al-Ani, Aysha H.
    Vaughan, Rose
    Christensen, Britt
    Bryant, Robert V.
    Novak, Kerri L.
    BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1137):
  • [48] Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero
    Flanagan, Emma
    Prentice, Ralley
    Wright, Emily K.
    Gibson, Peter R.
    Ross, Alyson L.
    Begun, Jakob
    Sparrow, Miles P.
    Goldberg, Rimma
    Rosella, Ourania
    Burns, Megan
    Kiburg, Katerina, V
    Bell, Sally J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (06) : 700 - 704
  • [49] INFLIXIMAB TROUGH LEVELS AFTER INDUCTION THERAPY: A PREDICTIVE FACTOR FOR OUTCOME IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    van Hoeve, Karen
    Hoffman, Ilse
    Dreesen, Erwin
    Ferrante, Marc
    Ann, Gils
    Vermeire, Severine
    GASTROENTEROLOGY, 2018, 154 (06) : S1042 - S1043
  • [50] Early vedolizumab trough levels are not associated with a short-term response in patients with inflammatory bowel disease
    Pudilova, K.
    Kolar, M.
    Duricova, D.
    Malickova, K.
    Hruba, V.
    Machkova, N.
    Vanickova, R.
    Mitrova, K.
    Lukas, M.
    Vasatko, M.
    Lukas, M.
    Bortlik, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S356 - S356
12345